H7N7 avian influenza virus live attenuated vaccine (Medimmune Vaccines)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameH7N7 avian influenza virus live attenuated vaccine (Medimmune Vaccines)

Drug Alias NameH7N7禽流感病毒减毒活疫苗-NIAID/MedImmunereassortant HP A/Netherlands/219/03 (H7N7) + A/Ann Arbor/6/60 ca (H2N2) (avian influenza virus infection)

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Live attenuated vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsInfluenza in Birds

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesNational Institute Of Allergy And Infectious Diseases (Niaid)Medimmune Llc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesMedimmune Llc National Institute Of Allergy And Infectious Diseases (Niaid)

Active IndicationsN/A

Inactive IndicationsInfluenza in Birds

Other Information

ATC CodeN/A